Cargando…

Preoperative systemic inflammation response index is an independent prognostic marker for BCG immunotherapy in patients with non‐muscle‐invasive bladder cancer

BACKGROUND: The Systemic Inflammatory Response Index (SIRI) is a novel prognostic biomarker based on peripheral blood counts of neutrophils, monocytes, and lymphocytes. Recent evidence suggests that it is associated with poor prognosis in various cancers. However, the predictive value of the SIRI in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Kun, Xiao, Ming, Li, Zitaiyu, He, Kancheng, Wang, Jinhua, Zhu, Liang, Xiong, Wei, Zhong, Zhaohui, Tang, Yuxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972176/ https://www.ncbi.nlm.nih.gov/pubmed/36214475 http://dx.doi.org/10.1002/cam4.5284

Ejemplares similares

Lymphocyte-to-Monocyte Ratio Is the Independent Prognostic Marker of Progression in Patients Undergoing BCG-Immunotherapy for Bladder Cancer
por: Adamkiewicz, Mateusz, et al.
Publicado: (2021)

BCG in Bladder Cancer Immunotherapy
por: Jiang, Song, et al.
Publicado: (2022)

Novel sequential therapy with metformin enhances the effects of cisplatin in testicular germ cell tumours via YAP1 signalling
por: He, Kancheng, et al.
Publicado: (2022)

Bladder Cancer Immunotherapy: BCG and Beyond
por: Askeland, Eric J., et al.
Publicado: (2012)

Role of urothelial cells in BCG immunotherapy for superficial bladder cancer
por: Bevers, R F M, et al.
Publicado: (2004)

Bladder Sparing Therapy for BCG Failures – I – Intravesical Immunotherapy
por: Messing, Edward M.
Publicado: (2017)

Preoperative peripheral plasma fibrinogen level is an independent prognostic marker in penile cancer
por: Ma, Chengquan, et al.
Publicado: (2016)

VEGF signaling mediates bladder neuroplasticity and inflammation in response to BCG
por: Saban, Marcia R, et al.
Publicado: (2011)

Multisystemic BCGitis: A rare complication of intravesical BCG immunotherapy for bladder cancer
por: Vilares, Ana T., et al.
Publicado: (2022)

The Prognostic and Clinicopathological Significance of Systemic Immune-Inflammation Index in Bladder Cancer
por: Li, Jinze, et al.
Publicado: (2022)

Preoperative prognostic nutritional index as an independent prognostic factor for resected ampulla of Vater cancer
por: Yoo, Young Jin, et al.
Publicado: (2020)

Novel intravesical bacterial immunotherapy induces rejection of BCG-unresponsive established bladder tumors
por: Moreo, Eduardo, et al.
Publicado: (2022)

BCG immunotherapy of rat sarcomata.
por: Baldwin, R. W., et al.
Publicado: (1973)

Preoperative neurocognitive function as an independent survival prognostic marker in primary glioblastoma
por: Liouta, Evangelia, et al.
Publicado: (2023)

Systemic BCG‐osis following intravesical BCG instillation for bladder carcinoma
por: Liaw, Frank, et al.
Publicado: (2017)

Renal Tuberculosis Following Intravesical Bacillus Calmette–Guérin (BCG) Immunotherapy for the Treatment of Bladder Cancer
por: Bajramovic, Senad, et al.
Publicado: (2020)

Mirabegron improves the irritative symptoms caused by BCG immunotherapy after transurethral resection of bladder tumors
por: Sun, Kai, et al.
Publicado: (2021)

Immunotherapy With Bacillus Calmette-Guerin (BCG) in a 16-Year-Old With Urothelial Bladder Carcinoma
por: Martinez-Thomas, Jose M, et al.
Publicado: (2022)

Emerging trends of BCG immunotherapy for bladder cancer in last decade: a bibliometric and visualization analysis
por: Chen, Xingfeng, et al.
Publicado: (2023)

BCG Immunotherapy of a Rat Sarcoma
por: Baldwin, R. W., et al.
Publicado: (1973)

Reparameterized multiobjective control of BCG immunotherapy
por: Yue, Rongting, et al.
Publicado: (2023)

Vascular graft infections caused by Mycobacterium bovis BCG after BCG immunotherapy for non-muscle-invasive bladder cancer: Case report and review of literature
por: Arsuffi, Stefania, et al.
Publicado: (2023)

Prognostic Value of Preoperative Systemic Immune-Inflammation Index in Patients with Cervical Cancer
por: Huang, Huaping, et al.
Publicado: (2019)

Polymorphisms of genes encoding cytokines predict the risk of high-grade bladder cancer and outcomes of BCG immunotherapy
por: KRAJEWSKI, WOJCIECH, et al.
Publicado: (2020)

Bladder Cancer Immunotherapy by BCG Is Associated with a Significantly Reduced Risk of Alzheimer’s Disease and Parkinson’s Disease
por: Klinger, Danielle, et al.
Publicado: (2021)

Prognostic significance of preoperative serum inflammation markers in patients with male breast cancer
por: Li, Xing, et al.
Publicado: (2021)

The prognostic value of the systemic immune-inflammation index for patients with bladder cancer after radical cystectomy
por: Zhang, Shiyu, et al.
Publicado: (2022)

Prognostic value of preoperative inflammation-based predictors in patients with bladder carcinoma after radical cystectomy
por: Gui, Huiming, et al.
Publicado: (2021)

Prognostic role of systemic inflammation indexes in metastatic urothelial carcinoma treated with immunotherapy
por: Dionese, Michele, et al.
Publicado: (2023)

BCG Induced Necrosis of the Entire Bladder Urothelium
por: Krönig, Malte, et al.
Publicado: (2015)

Recognition and Treatment of BCG Failure in Bladder Cancer
por: Lightfoot, Andrew J., et al.
Publicado: (2011)

The use of intravesical BCG in urothelial carcinoma of the bladder
por: Alhunaidi, Omar, et al.
Publicado: (2019)

BCG-Mediated Bladder Cancer Immunotherapy: Identifying Determinants of Treatment Response Using a Calibrated Mathematical Model
por: Rentsch, Cyrill A., et al.
Publicado: (2013)

Response of high-risk of recurrence/progression bladder tumours expressing sialyl-Tn and sialyl-6-T to BCG immunotherapy
por: Lima, L, et al.
Publicado: (2013)

Preoperative systemic immune-inflammation index as a prognostic indicator for patients with urothelial carcinoma
por: Zheng, Jianxiong, et al.
Publicado: (2023)

Usefulness of Preoperative High Systemic Immune-Inflammation Index as a Prognostic Biomarker in Patients Who Undergo Radical Cystectomy for Bladder Cancer: Multicenter Analysis
por: Yamashita, Shimpei, et al.
Publicado: (2021)

Postoperative, but not preoperative, inflammation-based prognostic markers are prognostic factors in stage III colorectal cancer patients
por: Yasui, Kohei, et al.
Publicado: (2020)

Prognostic Role of Preoperative Neutrophil-To-Lymphocyte Ratio (NLR) and Recurrence at First Evaluation after Bacillus Calmette–Guérin (BCG) Induction in Non-Muscle-Invasive Bladder Cancer
por: Lee, Junghoon, et al.
Publicado: (2023)

Preoperative Systemic Inflammatory Markers as a Significant Prognostic Factor After TURBT in Patients with Non-Muscle-Invasive Bladder Cancer
por: Ding, Li, et al.
Publicado: (2023)

Preoperative neutrophil-to-lymphocyte ratio is an independent prognostic marker in patients with laryngeal squamous cell carcinoma
por: Tu, Xiu-Ping, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_98ad0gmjpgnppmit1ig8oosv0e